The Effect of Listening to Qur'an Recital on Quality of Life in Systemic Lupus Erythematosus Patients

NCT06263764 | Recruiting

• 1 other identifier: 23-11-1954
• Study Type: interventional
• Target: 70
• Locations: 1 country
• Sites: 1

Brief Summary

The goal of this quasi-experimental study is to evaluate the effect of listening to the Qur'an recital on quality of life among systemic lupus erythematosus patients. There will be intervention and control groups. Before the intervention, the quality of life of participants will be assessed using the Lupus-QoL questionnaire. After the baseline assessment, participants in the intervention group will be asked to listen to a Qur'an recital by Surah Ar-Rahman using an MP3 player twice a day for a minimum of 15 minutes each for 40 days. The control group will not receive any specific intervention and will continue with their usual routine. After the 40-day intervention period, the quality of life of participants in both groups will be assessed using the Lupus-QoL questionnaire. The results will be analyzed to determine if there is a significant improvement in quality of life. Besides, potential confounding factors such as SLE clinical manifestations, disease activity, pharmacologic treatment regimen, anxiety/depression, comorbidities, age, and economic status will also be collected before and after intervention to evaluate its effect on the quality of life.

Conditions

Quality of Life

Keywords

Quran Recital; Systemic Lupus Erythematosus

Outcome Measures

Primary Outcomes (1)

• Difference in Quality of Life Pre and Post Intervention

  Difference in quality of life score (Lupus-QoL score)

  40 days

Study Arms (2)

Qur'an Arm

EXPERIMENTAL

Participants in the intervention group will be asked to listen to a Qur'an recital by Surah Ar-Rahman using an MP3 player twice a day for a minimum of 15 minutes each for 40 days. The participants will listen to the same Qur'an recital (recited by Freed Ghalib) using the same MP3 player.

Other: Listening to Qur'an Recital

Control Arm

NO INTERVENTION

The control group will not receive any specific intervention and will continue with their usual routine

Interventions

Listening to Qur'an Recital OTHER

Listening to Surah Ar Rahman twice a day for minimum 15 minutes each for 40 days

Qur'an Arm

Eligibility Criteria

• Age: 18 Years - 65 Years
• Gender Eligibility Details: Female
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64), Older Adult (65+)

You may qualify if:

• Systemic Lupus Erythematosus Patients based on EULAR/ACR 2019 diagnostic criteria,
• Female aged ≥ 18 years old,
• Muslim (follower of the religion of Islam),
• Have no auditory problems,
• Received a steroid dose ≤ 20 mg/day equivalent to prednisone,

You may not qualify if:

• Cannot read or write,
• Using drugs that affect the work of the central nervous system,
• Not willing to take part in research.

Sponsors & Collaborators

• Indonesia University: lead

Study Sites (1)

Faculty of Medicine Universitas Indonesia -Cipto Mangunkusumo Hospital, Jakarta, Indonesia

Jakarta, 10430, Indonesia

RECRUITING

Related Publications (1)

• Rafique R, Anjum A, Raheem SS. Efficacy of Surah Al-Rehman in Managing Depression in Muslim Women. J Relig Health. 2019 Apr;58(2):516-526. doi: 10.1007/s10943-017-0492-z.

  PMID: 28900859 BACKGROUND

MeSH Terms

Conditions

Lupus Erythematosus, Systemic

Condition Hierarchy (Ancestors)

Connective Tissue Diseases; Skin and Connective Tissue Diseases; Autoimmune Diseases; Immune System Diseases

Study Officials

• Rudi Putranto, PhD

  Department of Internal Medicine, Faculty of Medicine Universitas Indonesia

  STUDY DIRECTOR

• Sukamto Koesnoe, PhD

  Department of Internal Medicine, Faculty of Medicine Universitas Indonesia

  STUDY DIRECTOR

• Alvina Widhani, PhD

  Department of Internal Medicine, Faculty of Medicine Universitas Indonesia

  PRINCIPAL INVESTIGATOR

• Karina Wijayanti, MD

  Department of Internal Medicine, Faculty of Medicine Universitas Indonesia

  PRINCIPAL INVESTIGATOR

Central Study Contacts

Alvina Widhani, PhD

CONTACT

+6281905910034; alvina.widhani@gmail.com

Karina Wijayanti, MD

CONTACT

085226207270; karinawija@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: NON RANDOMIZED
• Masking: DOUBLE
• Who Masked: PARTICIPANT, CARE PROVIDER
• Purpose: SUPPORTIVE CARE
• Intervention Model: PARALLEL
• Sponsor Type: OTHER
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Staff of Allergy Immunology Division, Department of Internal Medicine, Faculty of Medicine Universitas Indonesia

Study Record Dates

• First Submitted: February 8, 2024
• First Posted: February 16, 2024
• Study Start: February 12, 2024
• Primary Completion: June 30, 2024
• Study Completion: July 31, 2024
• Last Updated: February 16, 2024

Record last verified: 2024-02

Data Sharing

• IPD Sharing: Will not share

Locations

ID (1)